<DOC>
	<DOCNO>NCT01710436</DOCNO>
	<brief_summary>This study prospective , observational study estimate relationship dosage clopidogrel platelet aggregation Chinese different genotype . The investigator suppose pretreatment dosage clopidogrel percutaneous coronary intervention ( PCI ) CYP2C19 genotype may effect platelet aggregation well clinical outcome .</brief_summary>
	<brief_title>Relationship Between Dosage Clopidogrel Platelet Aggregation Chinese With Different Genotype</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>accept PCI Chinese CHD patient expect dual antiplatelet therapy ( DAPT ) least 6 month another plan PCI within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>